Dendritic cell vaccination and immune monitoring

被引:0
作者
E. H. J. G. Aarntzen
C. G. Figdor
G. J. Adema
C. J. A. Punt
I. J. M. de Vries
机构
[1] Nijmegen Centre for Molecular Life Sciences,Department of Medical Oncology
[2] Radboud University Nijmegen Medical Centre,Department of Tumor Immunology
[3] Nijmegen Centre for Molecular Life Sciences,Department of Pediatric Hemato
[4] Radboud University Nijmegen Medical Centre,Oncology
[5] Nijmegen Centre for Molecular Life Sciences,undefined
[6] Radboud University Nijmegen Medical Centre,undefined
来源
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词
Dendritic cells; Specific immune responses; Migration; mRNA transfection; In vivo targeting;
D O I
暂无
中图分类号
学科分类号
摘要
We exploited dendritic cells (DC) to vaccinate melanoma patients. We recently demonstrated a statistical significant correlation between favorable clinical outcome and the presence of vaccine-related tumor antigen-specific T cells in delayed type hypersensitivity (DTH) skin biopsies. However, favorable clinical outcome is only observed in a minority of the treated patients. Therefore, it is obvious that current DC-based protocols need to be improved. For this reason, we study in small proof of principle trials the fate, interactions and effectiveness of the injected DC.
引用
收藏
页码:1559 / 1568
页数:9
相关论文
共 50 条
  • [1] Dendritic cell vaccination and immune monitoring
    Aarntzen, E. H. J. G.
    Figdor, C. G.
    Adema, G. J.
    Punt, C. J. A.
    de Vries, I. J. M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (10) : 1559 - 1568
  • [2] Dendritic cell vaccination and immune monitoring
    Aarntzen, E. H. J. G.
    Figdor, C. G.
    Adema, G. J.
    Punt, C. J. A.
    de Vries, I. J. M.
    ISBT SCIENCE SERIES, VOL 4, NO 1, STATE OF THE ART PRESENTATIONS, 2009, 4 (01): : 18 - +
  • [3] Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer
    Goyne, Hannah E.
    Cannon, Martin J.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [4] Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies
    Zanotta, Serena
    Galati, Domenico
    De Filippi, Rosaria
    Pinto, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [5] IMMUNE MONITORING OF DENDRITIC CELL-BASED CANCER VACCINE IN GLIOBLASTOMA PATIENTS
    Skachkova, O., V
    Gorbach, O., I
    Khranovska, N. M.
    Glavatskyi, O. Ya
    Khmelnytskyi, H., V
    Shuba, I. M.
    Shevelov, M. M.
    Zemskova, O., V
    WORLD OF MEDICINE AND BIOLOGY, 2021, 77 (03): : 152 - 157
  • [6] Dendritic cell vaccination for cancer therapy
    Nestle, FO
    ONCOGENE, 2000, 19 (56) : 6673 - 6679
  • [7] Dendritic cell vaccination for cancer therapy
    Frank O Nestle
    Oncogene, 2000, 19 : 6673 - 6679
  • [8] Dendritic cell vaccination in autoimmune disease
    Gross, Catharina C.
    Wiendl, Heinz
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (02) : 268 - 274
  • [9] Role of osteopontin in dendritic cell shaping of immune responses
    Del Prete, Annalisa
    Scutera, Sara
    Sozzani, Silvano
    Musso, Tiziana
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 50 : 19 - 28
  • [10] Dendritic cell vaccination in acute myeloid leukemia
    Anguille, Sebastien
    Willemen, Yannick
    Lion, Eva
    Smits, Evelien L.
    Berneman, Zwi N.
    CYTOTHERAPY, 2012, 14 (06) : 647 - 656